Regulation of metabolism by the innate immune system

Nature Reviews Endocrinology

Volumn 12, Issue 1, 2016, Pages 15-20

  Lackey, Denise E ^a   Olefsky, Jerrold M ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIBODY; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INSULIN; SALSALATE; STRESS ACTIVATED PROTEIN KINASE;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; CHEMOTAXIS; DIET; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE FLORA; KUPFFER CELL; LIVER; LYMPHOID CELL; MACROPHAGE; MAST CELL; METABOLIC REGULATION; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; OBESITY; PANCREAS ISLET; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; ENERGY METABOLISM; IMMUNOLOGY; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INSULIN RESISTANCE; OBESITY;

EID: 84949627236     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2015.189     Document Type: Review

References (190)

1. Kahn, S. E., Hull, R. L., & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846 (2006
2. Despres, J. P., & Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 444, 881-887 (2006
3. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. CDC [online], http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf (2014
4. Heilbronn, L. K., & Campbell, L. V. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr. Pharm. Des. 14, 1225-1230 (2008
5. Lumeng, C. N., & Saltiel, A. R. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121, 2111-2117 (2011
6. Osborn, O., & Olefsky, J. M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18, 363-374 (2012
7. Weisberg, S. P., et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003
8. Brestoff, J. R., & Artis, D. Immune regulation of metabolic homeostasis in health and disease. Cell 161, 146-160 (2015
9. McNelis, J. C., & Olefsky, J. M. Macrophages, immunity, and metabolic disease. Immunity 41, 36-48 (2014
10. Sell, H., Habich, C., & Eckel, J. Adaptive immunity in obesity and insulin resistance. Nat. Rev. Endocrinol. 8, 709-716 (2012
11. Mathis, D. Immunological goings-on in visceral adipose tissue. Cell Metab. 17, 851-859 (2013
12. Cipolletta, D. Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential. Immunology 142, 517-525 (2014
13. Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 87-91 (1993
14. Baker, R. G., Hayden, M. S., & Ghosh, S. NF ?B, inflammation, and metabolic disease. Cell Metab. 13, 11-22 (2011
15. Tornatore, L., Thotakura, A. K., Bennett, J., Moretti, M., & Franzoso, G. The nuclear factor ? B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol. 22, 557-566 (2012
16. Yin, M J., Yamamoto, Y., & Gaynor, R. B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I?B kinase β. Nature 396, 77-80 (1998
17. Yuan, M., et al. Reversal of obesity-And diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 293, 1673-1677 (2001
18. Shoelson, S. E., Lee, J., & Yuan, M. Inflammation and the IKKβ/I?B/NF ?B axis in obesity-And diet-induced insulin resistance. Int. J. Obes. Relat. Metab. Disord. 27, S49-S52 (2003
19. Hirosumi, J., et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333-336 (2002
20. Sabio, G., et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322, 1539-1543 (2008
21. Solinas, G., et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 6, 386-397 (2007
22. Solinas, G., & Karin, M. JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction. FASEB J. 24, 2596-2611 (2010
23. Yin, J., et al. Palmitate induces endoplasmic reticulum stress and autophagy in mature adipocytes: implications for apoptosis and inflammation. Int. J. Mol. Med. 35, 932-940 (2015
24. Chen, Y. Y., et al. Palmitate induces autophagy in pancreatic β cells via endoplasmic reticulum stress and its downstream JNK pathway. Int. J. Mol. Med. 32, 1401-1406 (2013
25. Gual, P., Le Marchand-Brustel, Y., & Tanti, J. F. Positive and negative regulation of insulin signaling through IRS 1 phosphorylation. Biochimie 87, 99-109 (2005
26. Westwell-Roper, C., Nackiewicz, D., Dan, M., & Ehses, J. A. Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes. Immunol. Cell Biol. 92, 314-323 (2014
27. Masters, S. L., et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL 1β in type 2 diabetes. Nat. Immunol. 11, 897-904 (2010
28. Haneklaus, M., & O'Neill, L. A. NLRP3 at the interface of metabolism and inflammation. Immunol. Rev. 265, 53-62 (2015
29. Stienstra, R., et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl Acad. Sci. USA 108, 15324-15329 (2011
30. Vandanmagsar, B., et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179-188 (2011
31. Youm, Y. H., et al. The ketone metabolite β hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21, 263-269 (2015
32. Finucane, O. M., et al. Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL 1β secretion and insulin resistance despite obesity. Diabetes 64, 2116-2128 (2015
33. Lagathu, C., et al. Long-Term treatment with interleukin 1β induces insulin resistance in murine and human adipocytes. Diabetologia 49, 2162-2173 (2006
34. Sauter, N. S., Schulthess, F. T., Galasso, R., Castellani, L. W., & Maedler, K. The antiinflammatory cytokine interleukin 1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 149, 2208-2218 (2008
35. Larsen, C. M., et al. Interleukin 1 receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517-1526 (2007
36. Gao, D., et al. Interleukin 1β mediates macrophage-induced impairment of insulin signaling in human primary adipocytes. Am. J. Physiol. Endocrinol. Metab. 307, E289-E304 (2014
37. Koenen, T. B., et al. The inflammasome and caspase 1 activation: a new mechanism underlying increased inflammatory activity in human visceral adipose tissue. Endocrinology 152, 3769-3778 (2011
38. Lee, J. Y., Sohn, K. H., Rhee, S. H., & Hwang, D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase 2 mediated through Toll-like receptor 4. J. Biol. Chem. 276, 16683-16689 (2001
39. Shi, H., et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025 (2006
40. Pal, D., et al. Fetuin A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. 18, 1279-1285 (2012
41. Guo, S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J. Endocrinol. 220, T1-T23 (2014
42. Werner, E. D., Lee, J., Hansen, L., Yuan, M., & Shoelson, S. E. Insulin resistance due to phosphorylation of insulin receptor substrate 1 at serine 302. J. Biol. Chem. 279, 35298-35305 (2004
43. Yaspelkis, B. B. 3rd, Kvasha, I. A., & Figueroa, T. Y. High-fat feeding increases insulin receptor and IRS 1 coimmunoprecipitation with SOCS 3, IKKα/β phosphorylation and decreases PI 3 kinase activity in muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R1709-R1715 (2009
44. Zolotnik, I. A., Figueroa, T. Y., & Yaspelkis, B. B. 3rd. Insulin receptor and IRS 1 co-immunoprecipitation with SOCS 3, and IKKα/β phosphorylation are increased in obese Zucker rat skeletal muscle. Life Sci. 91, 816-822 (2012
45. Poletto, A. C., et al. Oleic and linoleic fatty acids downregulate Slc2a4/GLUT4 expression via NFKB and SREBP1 in skeletal muscle cells. Mol. Cell. Endocrinol. 401, 65-72 (2015
46. Ruan, H., Hacohen, N., Golub, T. R., Van Parijs, L., & Lodish, H. F. Tumor necrosis factor α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3 L1 adipocytes: nuclear factor-?B activation by TNF α is obligatory. Diabetes 51, 1319-1336 (2002
47. Stephens, J. M., & Pekala, P. H. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3 L1 adipocytes by tumor necrosis factor α. J. Biol. Chem. 266, 21839-21845 (1991
48. Arner, P., & Kulyte, A. MicroRNA regulatory networks in human adipose tissue and obesity. Nat. Rev. Endocrinol. 11, 276-288 (2015
49. Chen, Q., et al Inducible microRNA 223 down-regulation promotes TLR-Triggered IL 6 and IL 1β production in macrophages by targeting STAT3. PLoS ONE 7, e42971 (2012
50. Liu, S., Yang, Y., & Wu, J. TNFα-induced up-regulation of miR 155 inhibits adipogenesis by down-regulating early adipogenic transcription factors. Biochem. Biophys. Res. Commun. 414, 618-624 (2011
51. Ge, Q., Brichard, S., Yi, X., & Li, Q. MicroRNAs as a new mechanism regulating adipose tissue inflammation in obesity and as a novel therapeutic strategy in the metabolic syndrome. J. Immunol. Res. 2014, 987285 (2014
52. Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367-377 (2008
53. Ussher, J. R., et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 59, 2453-2464 (2010
54. Holland, W. L., et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121, 1858-1870 (2011
55. van Diepen, J. A., et al. Hepatocyte-specific IKK β activation enhances VLDL-Triglyceride production in APOE 3 Leiden mice. J. Lipid Res. 52, 942-950 (2011
56. Xu, H., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003
57. Lumeng, C. N., Deyoung, S. M., & Saltiel, A. R. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am. J. Physiol. Endocrinol. Metab. 292, E166-E174 (2007
58. Lumeng, C. N., Deyoung, S. M., Bodzin, J. L., & Saltiel, A. R. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 56, 16-23 (2007
59. Patsouris, D., et al. Ablation of CD11c positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 8, 301-309 (2008
60. Li, P., et al. LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nat. Med. 21, 239-247 (2015
61. Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. Protection from obesity-induced insulin resistance in mice lacking TNF α function. Nature 389, 610-614 (1997
62. Spite, M., et al. Deficiency of the leukotriene B4 receptor, BLT 1, protects against systemic insulin resistance in diet-induced obesity. J. Immunol. 187, 1942-1949 (2011
63. Arkan, M. C., et al. IKK β links inflammation to obesity-induced insulin resistance. Nat. Med. 11, 191-198 (2005
64. Han, M. S., et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339, 218-222 (2013
65. Kraakman, M. J., et al. Blocking IL 6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance. Cell Metab. 21, 403-416 (2015
66. Wernstedt Asterholm, I., et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 20, 103-118 (2014
67. Chiang, S. H., et al. The protein kinase IKK? Regulates energy balance in obese mice. Cell 138, 961-975 (2009
68. Reilly, S. M., et al. An inhibitor of the protein kinases TBK1 and IKK-improves obesity-related metabolic dysfunctions in mice. Nat. Med. 19, 313-321 (2013
69. Mowers, J., et al. Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKK? and TBK1. eLIFE 2, e01119 (2013
70. Reilly, S. M., et al. A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis. Nat. Commun. 6, 6047 (2015
71. Holmes, A. G., et al. Prolonged interleukin 6 administration enhances glucose tolerance and increases skeletal muscle PPARα and UCP2 expression in rats. J. Endocrinol. 198, 367-374 (2008
72. Carey, A. L., et al. Interleukin 6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-Activated protein kinase. Diabetes 55, 2688-2697 (2006
73. Kim, H. J., et al. Differential effects of interleukin 6 and 10 on skeletal muscle and liver insulin action in vivo. Diabetes 53, 1060-1067 (2004
74. Kim, J. K., et al. PKC knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114, 823-827 (2004
75. Lundman, P., et al. A high-fat meal is accompanied by increased plasma interleukin 6 concentrations. Nutr. Metab. Cardiovasc. Dis. 17, 195-202 (2007
76. Aljada, A., et al. Increase in intranuclear nuclear factor ?B and decrease in inhibitor ?B in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am. J. Clin. Nutr. 79, 682-690 (2004
77. van Oostrom, A. J., et al. Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis 177, 175-182 (2004
78. Kim, J. I., et al. Lipid-overloaded enlarged adipocytes provoke insulin resistance independent of inflammation. Mol. Cell. Biol. 35, 1686-1699 (2015
79. Kim, J. K., et al. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J. Clin. Invest. 113, 756-763 (2004
80. Lee, Y. S., et al. Inflammation is necessary for long-Term but not short-Term high-fat diet-induced insulin resistance. Diabetes 60, 2474-2483 (2011
81. Gordon, S., & Martinez, F. O. Alternative activation of macrophages: mechanism and functions. Immunity 32, 593-604 (2010
82. Sica, A., & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787-795 (2012
83. Murray, P. J., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14-20 (2014
84. Xu, X., et al. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 18, 816-830 (2013
85. Kratz, M., et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metab. 20, 614-625 (2014
86. Li, P., et al. Functional heterogeneity of CD11c positive adipose tissue macrophages in diet-induced obese mice. J. Biol. Chem. 285, 15333-15345 (2010
87. Hui, X., et al. Adiponectin enhances cold-induced browning of subcutaneous adipose tissue via promoting M2 macrophage proliferation. Cell Metab. 22, 279-290 (2015
88. Patsouris, D., et al. Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage chemotaxis and recruitment. J. Biol. Chem. 284, 31223-31235 (2009
89. Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184 (2007
90. Oh, D. Y., Morinaga, H., Talukdar, S., Bae, E. J., & Olefsky, J. M. Increased macrophage migration into adipose tissue in obese mice. Diabetes 61, 346-354 (2012
91. Inouye, K. E., et al. Absence of CC chemokine ligand 2 does not limit obesity-Associated infiltration of macrophages into adipose tissue. Diabetes 56, 2242-2250 (2007
92. Kirk, E. A., Sagawa, Z. K., McDonald, T. O., O'Brien, K. D., & Heinecke, J. W. Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue. Diabetes 57, 1254-1261 (2008
93. Shimizu, I., et al. Semaphorin3E induced inflammation contributes to insulin resistance in dietary obesity. Cell Metab. 18, 491-504 (2013
94. Eguchi, A., et al. Microparticles release by adipocytes act as 'find-me' signals to promote macrophage migration. PLoS ONE 10, e0123110 (2015
95. Lumeng, C. N., DelProposto, J. B., Westcott, D. J., & Saltiel, A. R. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 57, 3239-3246 (2008
96. Odegaard, J. I., et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447, 1116-1120 (2007
97. Hevener, A. L., et al. Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J. Clin. Invest. 117, 1658-1669 (2007
98. O'Rourke, R. W., et al. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN γ in inflammation in human adipose tissue. Int. J. Obes. (Lond.) 33, 978-990 (2009
99. Revelo, X. S., et al. Perforin is a novel immune regulator of obesity-related insulin resistance. Diabetes 64, 90-103 (2015
100. O'Rourke, R. W., et al. Systemic NK cell ablation attenuates intra-Abdominal adipose tissue macrophage infiltration in murine obesity. Obesity (Silver Spring) 22, 2109-2114 (2014
101. Wensveen, F. M., et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat. Immunol. 16, 376-385 (2015
102. Liu, J., et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 15, 940-945 (2009
103. Divoux, A., et al. Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes. J. Clin. Endocrinol. Metab. 97, E1677-E1685 (2012
104. Gutierrez, D. A., Muralidhar, S., Feyerabend, T. B., Herzig, S., & Rodewald, H. R. Hematopoietic Kit deficiency, rather than lack of mast cells, protects mice from obesity and insulin resistance. Cell Metab. 21, 678-691 (2015
105. Wu, D., et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332, 243-247 (2011
106. Hussaarts, L., et al. Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice. FASEB J. 29, 3027-3039 (2015
107. Takatsu, K., & Nakajima, H. IL 5 and eosinophilia. Curr. Opin. Immunol. 20, 288-294 (2008
108. Nussbaum, J. C., et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502, 245-248 (2013
109. Molofsky, A. B., et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210, 535-549 (2013
110. Hams, E., Locksley, R. M., McKenzie, A. N., & Fallon, P. G. Cutting edge: IL 25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J. Immunol. 191, 5349-5353 (2013
111. Harms, M., & Seale, P. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19, 1252-1263 (2013
112. Wu, J., Cohen, P., & Spiegelman, B. M. Adaptive thermogenesis in adipocytes: is beige the new brown? Genes Dev. 27, 234-250 (2013
113. Bartelt, A., & Heeren, J. Adipose tissue browning and metabolic health. Nat. Rev. Endocrinol. 10, 24-36 (2014
114. Nguyen, K. D., et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480, 104-108 (2011
115. Qiu, Y., et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 157, 1292-1308 (2014
116. Brestoff, J. R., et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242-246 (2015
117. Brennan, P. J., Brigl, M., & Brenner, M. B. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 13, 101-117 (2013
118. Ji, Y., et al. Activation of natural killer T cells promotes M2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin 4 (IL 4)/STAT6 protein signaling axis in obesity. J. Biol. Chem. 287, 13561-13571 (2012
119. Lynch, L., et al. Invariant NKT cells and CD1d+ cells amass in human omentum and are depleted in patients with cancer and obesity. Eur. J. Immunol. 39, 1893-1901 (2009
120. Lynch, L., et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 37, 574-587 (2012
121. Huh, J. Y., et al. A novel function of adipocytes in lipid antigen presentation to iNKT cells. Mol. Cell. Biol. 33, 328-339 (2013
122. Lynch, L., et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of TReg cells and macrophages in adipose tissue. Nat. Immunol. 16, 85-95 (2015
123. Ji, Y., et al. Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin 4. J. Biol. Chem. 287, 24378-24386 (2012
124. Mantell, B. S., et al. Mice lacking NKT cells but with a complete complement of CD8+ T cells are not protected against the metabolic abnormalities of diet-induced obesity. PLoS ONE 6, e19831 (2011
125. Kotas, M. E., et al. Impact of CD1d deficiency on metabolism. PLoS ONE 6, e25478 (2011
126. Wu, L., et al. Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Proc. Natl Acad. Sci. USA 109, E1143-E1152 (2012
127. Strodthoff, D., et al. Lack of invariant natural killer T cells affects lipid metabolism in adipose tissue of diet-induced obese mice. Arterioscler. Thromb. Vasc. Biol. 33, 1189-1196 (2013
128. Lynch, L. Adipose invariant natural killer T cells. Immunology 142, 337-346 (2014
129. Tencerova, M., et al. Activated Kupffer cells inhibit insulin sensitivity in obese mice. FASEB J. 29, 2959-2969 (2015
130. Pardo, V., Gonzalez-Rodriguez, A., Guijas, C., Balsinde, J., & Valverde, A. M. Opposite cross-Talk by oleate and palmitate on insulin signaling in hepatocytes through macrophage activation. J. Biol. Chem. 290, 11663-11677 (2015
131. Dey, A., Allen, J., & Hankey-Giblin, P. A. Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages. Front. Immunol. 5, 683 (2014
132. Obstfeld, A. E., et al. C C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes 59, 916-925 (2010
133. Morinaga, H., et al. Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice. Diabetes 64, 1120-1130 (2015
134. Ramachandran, P., et al. Differential Ly 6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl Acad. Sci. USA 109, E3186-E3195 (2012
135. Zigmond, E., et al. Infiltrating monocyte-derived macrophages and resident Kupffer cells display different ontogeny and functions in acute liver injury. J. Immunol. 193, 344-353 (2014
136. Huang, W., et al. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 59, 347-357 (2010
137. Lanthier, N., et al. Kupffer cell activation is a causal factor for hepatic insulin resistance. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G107-G116 (2010
138. Bikman, B. T., & Summers, S. A. Ceramides as modulators of cellular and whole-body metabolism. J. Clin. Invest. 121, 4222-4230 (2011
139. Schubert, K. M., Scheid, M. P., & Duronio, V. Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J. Biol. Chem. 275, 13330-13335 (2000
140. Fink, L. N., et al. Pro-inflammatory macrophages increase in skeletal muscle of high fat-fed mice and correlate with metabolic risk markers in humans. Obesity (Silver Spring) 22, 747-757 (2014
141. Fink, L. N., et al. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes. Diabetologia 56, 1623-1628 (2013
142. Varma, V., et al. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am. J. Physiol. Endocrinol. Metab. 296, E1300-E1310 (2009
143. Patsouris, D., et al. Insulin resistance is associated with MCP1 mediated macrophage accumulation in skeletal muscle in mice and humans. PLoS ONE 9, e110653 (2014
144. Boon, M. R., et al. Short-Term high-fat diet increases macrophage markers in skeletal muscle accompanied by impaired insulin signalling in healthy male subjects. Clin. Sci. (Lond.) 128, 143-151 (2015
145. Pillon, N. J., Arane, K., Bilan, P. J., Chiu, T. T., & Klip, A. Muscle cells challenged with saturated fatty acids mount an autonomous inflammatory response that activates macrophages. Cell Commun. Signal. 10, 30 (2012
146. Richardson, S. J., Willcox, A., Bone, A. J., Foulis, A. K., & Morgan, N. G. Islet-Associated macrophages in type 2 diabetes. Diabetologia 52, 1686-1688 (2009
147. Ehses, J. A., et al. Increased number of islet-Associated macrophages in type 2 diabetes. Diabetes 56, 2356-2370 (2007
148. Jourdan, T., et al. Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates β cell loss in type 2 diabetes. Nat. Med. 19, 1132-1140 (2013
149. Eguchi, K., et al. Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. Cell Metab. 15, 518-533 (2012
150. Morris, D. L. Minireview: emerging concepts in islet macrophage biology in type 2 diabetes. Mol. Endocrinol. 29, 946-962 (2015
151. Donath, M. Y., & Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107 (2011
152. Boni-Schnetzler, M., et al Free Fatty Acids Induce A Proinflammatory Response in Islets Via the Abundantly Expressed Interleukin 1 Receptor I. Endocrinology 150, 5218-5229 (2009
153. Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136-140 (2010
154. Hasnain, S. Z., et al. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate β cell stress. Nat. Med. 20, 1417-1426 (2014
155. Sauter, N. S., et al. Angiotensin II induces interleukin 1β mediated islet inflammation and β cell dysfunction independently of vasoconstrictive effects. Diabetes 64, 1273-1283 (2015
156. Tremaroli, V., & Backhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242-249 (2012
157. Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023 (2006
158. Turnbaugh, P. J., et al. An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031 (2006
159. Turnbaugh, P. J., Backhed, F., Fulton, L., & Gordon, J. I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223 (2008
160. Caesar, R., et al. Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut 61, 1701-1707 (2012
161. Teixeira, T. F., et al. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin. Nutr. 31, 735-740 (2012
162. Amar, J., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol. Med. 3, 559-572 (2011
163. Cani, P. D., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481 (2008
164. Johnson, A. M., et al. High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability. PLoS ONE 10, e0122195 (2015
165. Wang, X., et al. Interleukin 22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514, 237-241 (2014
166. Goldfine, A. B., et al. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin. Transl. Sci. 1, 36-43 (2008
167. Goldfine, A. B., et al. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 152, 346-357 (2010
168. Goldfine, A. B., et al. A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia 56, 714-723 (2013
169. Barzilay, J. I., et al. The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes. Diabetes Care 37, 1083-1091 (2014
170. Raghavan, R. P., Laight, D. W., & Cummings, M. H. Aspirin in type 2 diabetes, a randomised controlled study: effect of different doses on inflammation, oxidative stress, insulin resistance and endothelial function. Int. J. Clin. Pract. 68, 271-277 (2014
171. Xiao, C., Giacca, A., & Lewis, G. F. The effect of high-dose sodium salicylate on chronically elevated plasma nonesterified fatty acid-induced insulin resistance and β cell dysfunction in overweight and obese nondiabetic men. Am. J. Physiol. Endocrinol. Metab. 297, E1205-E1211 (2009
172. Fernandez-Real, J. M., et al. Salicylates increase insulin secretion in healthy obese subjects. J. Clin. Endocrinol. Metab. 93, 2523-2530 (2008
173. Wascher, T. C., et al. Chronic TNF α neutralization does not improve insulin resistance or endothelial function in 'healthy' men with metabolic syndrome. Mol. Med. 17, 189-193 (2011
174. Stanley, T. L., et al. TNF α antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J. Clin. Endocrinol. Metab. 96, E146-E150 (2011
175. Solomon, D. H., et al. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 305, 2525-2531 (2011
176. Hensen, J., Howard, C. P., Walter, V., & Thuren, T. Impact of interleukin 1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: results of secondary endpoints from a randomized, placebo-controlled trial. Diabetes Metab. 39, 524-531 (2013
177. Cavelti-Weder, C., et al. Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35, 1654-1662 (2012
178. Sloan-Lancaster, J., et al. Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL 1β antibody, in patients with type 2 diabetes. Diabetes Care 36, 2239-2246 (2013
179. Esterson, Y. B., et al. Insulin sensitizing and anti-inflammatory effects of thiazolidinediones are heightened in obese patients. J. Investig. Med. 61, 1152-1160 (2013
180. Koppaka, S., et al. Reduced adipose tissue macrophage content is associated with improved insulin sensitivity in thiazolidinedione-Treated diabetic humans. Diabetes 62, 1843-1854 (2013
181. Cipolletta, D., et al. PPAR γ is a major driver of the accumulation and phenotype of adipose tissue TReg cells. Nature 486, 549-553 (2012
182. Ahmadian, M., et al. PPARγ signaling and metabolism: the good, the bad and the future. Nat. Med. 19, 557-566 (2013
183. Dutchak, P. A., et al. Fibroblast growth factor 21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Cell 148, 556-567 (2012
184. Oh, D. Y., et al. GPR120 is an ? 3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698 (2010
185. Spencer, M., et al. 3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance. Diabetes 62, 1709-1717 (2013
186. Tousoulis, D., et al. 3 PUFAs improved endothelial function and arterial stiffness with a parallel anti-inflammatory effect in adults with metabolic syndrome. Atherosclerosis 232, 10-16 (2014
187. Oh, D. Y., et al. A Gpr120 selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat. Med. 20, 942-947 (2014
188. Hanefeld, M., et al. Orally-Administered chemokine receptor CCR2 antagonist CCX140 B in type 2 diabetes: a pilot double-blind, randomized clinical trial. J. Diabetes Metab. 3, 225 (2012
189. Di Prospero, N. A., et al. CCR2 antagonism in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study. Diabetes Obes. Metab. 16, 1055-1064 (2014
190. Arora, T., et al. Roux en Y gastric bypass surgery induces early plasma metabolomic and lipidomic alterations in humans associated with diabetes remission. PLoS ONE 10, e0126401 (2015